Matches in SemOpenAlex for { <https://semopenalex.org/work/W2316742416> ?p ?o ?g. }
- W2316742416 endingPage "170" @default.
- W2316742416 startingPage "160" @default.
- W2316742416 abstract "In recent years, new prospects for the use of nucleic acids as anticancer drugs have been discovered. Aptamers for intracellular targets can regulate cellular functions and cause cell death or proliferation. However, intracellular aptamers have limited use for therapeutic applications due to their low bioavailability. In this work, we selected DNA aptamers to cell organelles and nucleus of cancer cells, and showed that an aptamer NAS-24 binds to vimentin and causes apoptosis of mouse ascites adenocarcinoma cells in vitro and in vivo. To deliver the aptamer NAS-24 inside cells, natural polysaccharide arabinogalactan was used as a carrier reagent. The mixture of arabinogalactan and NAS-24 was injected intraperitonealy for 5 days into mice with adenocarcinoma and inhibited adenocarcinoma growth more effectively than free arabinogalactan or the aptamer alone. The use of aptamers to intracellular targets together with arabinogalactan becomes a promising approach for anticancer therapy." @default.
- W2316742416 created "2016-06-24" @default.
- W2316742416 creator A5001407972 @default.
- W2316742416 creator A5010934398 @default.
- W2316742416 creator A5014987602 @default.
- W2316742416 creator A5015600580 @default.
- W2316742416 creator A5015611000 @default.
- W2316742416 creator A5016722675 @default.
- W2316742416 creator A5017901044 @default.
- W2316742416 creator A5018846183 @default.
- W2316742416 creator A5025988193 @default.
- W2316742416 creator A5029237008 @default.
- W2316742416 creator A5036406708 @default.
- W2316742416 creator A5036797671 @default.
- W2316742416 creator A5039832836 @default.
- W2316742416 creator A5066095241 @default.
- W2316742416 creator A5067145965 @default.
- W2316742416 creator A5077905225 @default.
- W2316742416 creator A5080376303 @default.
- W2316742416 date "2014-04-01" @default.
- W2316742416 modified "2023-09-30" @default.
- W2316742416 title "DNA-Aptamer Targeting Vimentin for Tumor Therapy <i>In Vivo</i>" @default.
- W2316742416 cites W1496474629 @default.
- W2316742416 cites W1964146045 @default.
- W2316742416 cites W1973546785 @default.
- W2316742416 cites W1992637082 @default.
- W2316742416 cites W1994869675 @default.
- W2316742416 cites W1995097523 @default.
- W2316742416 cites W2000105955 @default.
- W2316742416 cites W2006389926 @default.
- W2316742416 cites W2007070822 @default.
- W2316742416 cites W2021804270 @default.
- W2316742416 cites W2033145378 @default.
- W2316742416 cites W2033787987 @default.
- W2316742416 cites W2036294121 @default.
- W2316742416 cites W2036866144 @default.
- W2316742416 cites W2039508015 @default.
- W2316742416 cites W2043807918 @default.
- W2316742416 cites W204955954 @default.
- W2316742416 cites W2050968740 @default.
- W2316742416 cites W2066074720 @default.
- W2316742416 cites W2067605157 @default.
- W2316742416 cites W2069137487 @default.
- W2316742416 cites W2071270620 @default.
- W2316742416 cites W2075826965 @default.
- W2316742416 cites W2079321730 @default.
- W2316742416 cites W2080752012 @default.
- W2316742416 cites W2082288361 @default.
- W2316742416 cites W2092967426 @default.
- W2316742416 cites W2095935266 @default.
- W2316742416 cites W2104525153 @default.
- W2316742416 cites W2114017135 @default.
- W2316742416 cites W2116511587 @default.
- W2316742416 cites W2127454831 @default.
- W2316742416 cites W2147111331 @default.
- W2316742416 cites W2151784873 @default.
- W2316742416 cites W2153408949 @default.
- W2316742416 cites W2158325693 @default.
- W2316742416 cites W2162029104 @default.
- W2316742416 cites W2162321261 @default.
- W2316742416 cites W2163220944 @default.
- W2316742416 cites W2168517094 @default.
- W2316742416 cites W2321087328 @default.
- W2316742416 cites W2334141445 @default.
- W2316742416 cites W4232878258 @default.
- W2316742416 doi "https://doi.org/10.1089/nat.2013.0471" @default.
- W2316742416 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3962644" @default.
- W2316742416 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24410722" @default.
- W2316742416 hasPublicationYear "2014" @default.
- W2316742416 type Work @default.
- W2316742416 sameAs 2316742416 @default.
- W2316742416 citedByCount "45" @default.
- W2316742416 countsByYear W23167424162015 @default.
- W2316742416 countsByYear W23167424162016 @default.
- W2316742416 countsByYear W23167424162017 @default.
- W2316742416 countsByYear W23167424162018 @default.
- W2316742416 countsByYear W23167424162019 @default.
- W2316742416 countsByYear W23167424162020 @default.
- W2316742416 countsByYear W23167424162021 @default.
- W2316742416 countsByYear W23167424162022 @default.
- W2316742416 countsByYear W23167424162023 @default.
- W2316742416 crossrefType "journal-article" @default.
- W2316742416 hasAuthorship W2316742416A5001407972 @default.
- W2316742416 hasAuthorship W2316742416A5010934398 @default.
- W2316742416 hasAuthorship W2316742416A5014987602 @default.
- W2316742416 hasAuthorship W2316742416A5015600580 @default.
- W2316742416 hasAuthorship W2316742416A5015611000 @default.
- W2316742416 hasAuthorship W2316742416A5016722675 @default.
- W2316742416 hasAuthorship W2316742416A5017901044 @default.
- W2316742416 hasAuthorship W2316742416A5018846183 @default.
- W2316742416 hasAuthorship W2316742416A5025988193 @default.
- W2316742416 hasAuthorship W2316742416A5029237008 @default.
- W2316742416 hasAuthorship W2316742416A5036406708 @default.
- W2316742416 hasAuthorship W2316742416A5036797671 @default.
- W2316742416 hasAuthorship W2316742416A5039832836 @default.
- W2316742416 hasAuthorship W2316742416A5066095241 @default.
- W2316742416 hasAuthorship W2316742416A5067145965 @default.
- W2316742416 hasAuthorship W2316742416A5077905225 @default.